We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $680M
1-Year Est. Return 47.51%
This Fund
S&P 500
This Quarter Est. Return
+18.61%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$680M
AUM Growth
+$12.5M
Cap. Flow
-$82.1M
Cap. Flow %
-12.07%
Top 10 Hldgs %
19.1%
Holding
216
New
16
Increased
34
Reduced
132
Closed
17

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.52M
2
NRG icon
NRG Energy
NRG
+$6.36M
3
SNX icon
TD Synnex
SNX
+$5.16M
4
SYK icon
Stryker
SYK
+$3.97M
5
DE icon
Deere & Co
DE
+$3.68M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.62M
2
CRM icon
Salesforce
CRM
+$5.9M
3
EL icon
Estee Lauder
EL
+$5M
4
SANM icon
Sanmina
SANM
+$3.63M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.59M

Sector Composition

Rank Sector Weight
1 Financials 16.71%
2 Industrials 16.07%
3 Technology 15.33%
4 Healthcare 10.36%
5 Consumer Discretionary 6.12%

No holdings matched the selected filter criteria.

5 6 7 8 9

Similar funds

CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return

Oliver Luxxe Assets's Q2 2026 Portfolio in Review

As of Q2 2026, Oliver Luxxe Assets held 216 positions worth $680M, up 1.9% from $668M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oliver Luxxe Assets withdrew a net $82.1M in Q2 2026, closing 17 positions and reducing 132 holdings. Its most notable exit was HCA Healthcare, an estimated $6.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Oliver Luxxe Assets opened a new position in AstraZeneca worth $8.52M.

  • Oliver Luxxe Assets's largest Q2 2026 buy was AstraZeneca: 45,272 shares worth $8.52M.
  • Oliver Luxxe Assets added most to TE Connectivity in Q2 2026, an estimated $2.72M increase.
  • Oliver Luxxe Assets's biggest Q2 2026 reduction was Sanmina, cutting an estimated $3.63M.
  • Oliver Luxxe Assets fully exited HCA Healthcare in Q2 2026, selling an estimated $6.62M.
  • Oliver Luxxe Assets's ten largest holdings make up 19% of its $680M portfolio in Q2 2026.
  • Oliver Luxxe Assets opened 16 new positions and closed 17 in Q2 2026.
  • Oliver Luxxe Assets's portfolio value rose 1.9% quarter-over-quarter to $680M.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.